The combined model of CTCs, CA19-9, prealbumin, and peripheral lymphocyte count was efficient in predicting PM (Figure 3), suggesting that preoperative serum FR+ CTCs could serve as a non-invasive biomarker for predicting OPM in gastric cancer. Here, TTR is linked to gastric cancer.